Edesa Biotech is trading at $5.47 (5.8%) up in after-hours, rebounding from a 3.5% regular-session decline to $5.17 on light news flow.

  • The move lacks a clear fundamental catalyst, with no fresh earnings, regulatory filings, or company-specific headlines reported.
  • The after-hours gain likely reflects thin liquidity and short-term trading interest following recent volatility and profit-taking.